Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity

Basic and Clinical Pharmacology and Toxicology

Volumn 96, Issue 1, 2005, Pages 80-87

  Wattanapitayakul, Suvara K ^a   Chularojmontri, Linda ^b   Herunsalee, Angkana ^c   Charuchongkolwongse, Suphan ^c   Niumsakul, Somchit ^c   Bauer, John A ^d  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; CRYSTAL VIOLET; CURCUMA LONGA EXTRACT; DOXORUBICIN; EMBLICA OFFICINALIS EXTRACT; MORUS ALBA EXTRACT; PIPER ROSTRATUM EXTRACT; PLANT EXTRACT; SUPEROXIDE; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HEART PROTECTION; IC 50; MEDICINAL PLANT; MORUS ALBA; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PIPER ROSTRATUM; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG EVALUATION, PRECLINICAL; FERRIC COMPOUNDS; HELA CELLS; HUMANS; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PLANTS, MEDICINAL; RATS;

ANIMALIA; CURCUMA LONGA; EMBLICA; MORUS ALBA; PHYLLANTHUS EMBLICA; VIOLA (ANGIOSPERM);

EID: 13844318812     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto960112.x     Document Type: Article

References (48)

1. Abd-Allah, A., A. Al-Majed, A. Mostafa, O. Al-Shabanah, A. Din & M. Nagi: Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection. J. Biochem. Mol. Toxicol. 2002, 16, 254-259.
2. Anto, R. J., A. Mukhopadhyay, K. Denning & B. B. Aggarwal: Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-x1. Carcinogenesis 2002, 23, 143-150.
3. Arola, O. J., A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen & L. M. Voipio-Pulkki: Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000, 60, 1789-1792.
4. Bagchi, D., C. K. Sen, S. D. Ray, D. K. Das, M. Bagchi, H. G. Preuss & J. A. Vinson: Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res. 2003, 523-524, 87-97.
5. Benzie, I. & J. Strain: Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Meth. Enzymol. 1999, 299, 15-27.
6. Bhattacharya, A., S. Ghosal & S. K. Bhattacharya: Antioxidant activity of tannoid principles of Emblica officinalis (amla) in chronic stress induced changes in rat brain. Indian J. Exp. Biol. 2000a, 38, 877-880.
7. Bhattacharya, A., M. Kumar, S. Ghosal & S. K. Bhattacharya: Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine 2000b, 7, 173-175.
8. Breed, J. G., A. N. Zimmerman, J. A. Dormans & H. M. Pinedo: Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit. Cancer Res. 1980, 40, 2033-2038.
9. Breitbart, E., L. Lomnitski, A. Nyska, Z. Malik, M. Bergman, Y. Sofer, J. Haseman & S. Grossman: Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injury. Hum. Exp. Toxicol. 2001, 20, 337-345.
10. Chauhan, D. P.: Chemotherapeutic potential of curcumin for colorectal cancer. Curr. Pharm. Des. 2002, 8, 1695-1706.
11. Chautan, M., J. Leonardi, R. Calaf, P. Lechene, R. Grataroli, H. Portugal, A. M. Pauli, H. Lafont & G. Nalbone: Heart and liver membrane phospholipid homeostasis during acute administration of various antitumoral drugs to the rat. Biochem. Pharmacol. 1992, 44, 1139-1147.
12. Chopra, S., K. K. Pillai, S. Z. Husain & D. K. Giri: Propolis protects against doxorubicin-induced myocardiopathy in rats. Exp. Mol. Pathol. 1995, 62, 190-198.
13. De Beer, E., A. Bottone & E. Voest: Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur. J. Pharmacol. 2001, 451, 1-11.
14. DeAtley, S. M., M. Y. Aksenov, M. V. Aksenova, B. Harris, R. Hadley, P. Cole Harper, J. M. Carney & D. A. Butterfield: Anti-oxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Lett. 1999, 136, 41-46.
15. Dorr, R. T.: Cytoprotective agents for anthracyclines. Semin. Oncol. 1996, 23, 23-34.
16. Dziegiel, P., P. Surowiak & M. Zabel: Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage. Folia Histochem. Cytobiol. 2002, 40, 127-128.
17. Felker, G. M., R. E. Thompson, J. M. Hare, R. H. Hruban, D. E. Clemetson, D. L. Howard, K. L. Baughman & E. K. Kasper: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. New Engl. J. Med. 2000, 342, 1077-1084.
18. Fujita, K., K. Shinpo, K. Yamada, T. Sato, H. Niimi, M. Shamoto, T. Nagatsu, T. Takeuchi & H. Umezawa: Reduction of adriamycin toxicity by ascorbate in mice and guinea pigs. Cancer Res. 1982, 42, 309-316.
19. Green, P. S. & C. Leeuwenburgh: Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim. Biophys. Acta 2002, 1588, 94-101.
20. Griggs, J. J.: Reducing the toxicity of anticancer therapy: new strategies. Leuk. Res. 1998, 22 Suppl 1, S27-S33.
21. Haque, R., B. Bin-Hafeez, I. Ahmad, S. Parvez, S. Pandey & S. Raisuddin: Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum. Exp. Toxicol. 2001, 20, 643-650.
22. Jensen, B. V., T. Skovsgaard & S. L. Nielsen: Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. Ann. Oncol. 2002, 13, 699-709.
23. Kalivendi, S. V., S. Kotamraju, H. Zhao, J. Joseph & B. Kalyanaraman: Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of anti-apoptotic antioxidants and calcium. J. Biol. Chem. 2001, 276, 47266-47276.
24. Kozluca, O., E. Olcay, S. Surucu, Z. Guran, T. Kulaksiz & N. Uskent: Prevention of doxorubicin induced cardiotoxicity by catechin. Cancer Lett. 1996, 99, 1-6.
25. Kumar, D., H. Lou & P. K. Singal: Oxidative stress and apoptosis in heart dysfunction. Herz 2002, 27, 662-668.
26. Kumar, K. S. & K. Muller: Medicinal plants from Nepal; II. Evaluation as inhibitors of lipid peroxidation in biological membranes. J. Ethnopharmacol. 1999, 64, 135-139.
27. Legha, S. S., Y. M. Wang, B. Mackay, M. Ewer, G. N. Hortobagyi, R. S. Benjamin & M. K. Ali: Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann. N. Y. Acad. Sci. 1982, 393, 411-418.
28. Llesuy, S., P. Evelson, A. M. Campos & E. Lissi: Methodologies for evaluation of total antioxidant activities in complex mixtures. A critical review. Biol. Res. 2001, 34, 51-73.
29. Mehta, K., P. Pantazis, T. McQueen & B. B. Aggarwal: Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 1997, 8, 470-481.
30. Mimnaugh, E. G., Z. H. Siddik, R. Drew, B. I. Sikic & T. E. Gram: The effects of alpha-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice. Toxicol. Appl. Pharmacol. 1979, 49, 119-126.
31. Molyneux, C. A., M. C. Glyn & B. J. Ward: Oxidative stress and cardiac microvascular structure in ischemia and reperfusion: the protective effect of antioxidant vitamins. Microvasc. Res. 2002, 64, 265-277.
32. Pawlowska, J., J. Tarasiuk, E. Borowski, M. Wasowska, I. Oszczapowicz & C. R. Wolf: The ability of new formamidine sugar-modified derivatives of daunorubicin to stimulate free radical formation in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase and xanthine oxidase. Acta Biochim. Pol. 2000, 47, 141-147.
33. Pinto, J., G. B. Raiczyk, Y. P. Huang & R. S. Rivlin: New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer 1986, 58, 1911-1914.
34. Quiles, J. L., J. R. Huertas, M. Battino, J. Mataix & M. C. Ramirez-Tortosa: Antioxidant nutrients and adriamycin toxicity. Toxicology 2002, 180, 79-95.
35. Sabu, M. C. & R. Kuttan: Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J. Ethnopharmacol. 2002, 81, 155-160.
36. Sagach, V. F., M. Scrosati, J. Fielding, G. Rossoni, C. Galli & F. Visioli: The water-soluble vitamin E analogue Trolox protects against ischaemia/reperfusion damage in vitro and ex vivo. A comparison with vitamin E. Pharmacol. Res. 2002, 45, 435-439.
37. Saito, K., T. Oku, N. Ata, H. Miyashiro, M. Hattori & I. Saiki: A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors. Biol. Pharm. Bull. 1997, 20, 345-348.
38. Shimpo, K., T. Nagatsu, K. Yamada, T. Sato, H. Niimi, M. Shamoto, T. Takeuchi, H. Umezawa & K. Fujita: Ascorbic acid and adriamycin toxicity. Amer. J. Clin. Nutr. 1991a, 54, 1298S-1301S.
39. Shimpo, K., T. Nagatsu, K. Yamada, T. Sato, H. Niimi, M. Shamoto, T. Takeuchi, H. Umezawa & K. Fujita: Ascorbic acid and adriamycin toxicity. Amer. J. Clin. Nutr. 1991b, 54, 1298S-1301S.
40. Shinozawa, S., Y. Gomita & Y. Araki: Effect of high dose alpha-tocopherol acetate on the toxicity and tissue distribution of adriamycin (doxorubicin). Acta Med. Okayama 1988, 42, 253-258.
41. Shug, A. L.: Protection from adriamycin-induced cardiomyopathy in rats. Z. Kardiol. 1987, 76 Suppl 5, 46-52.
42. Takahashi, G., R. Montgomery, W. Stahl, C. Crittenden, M. Valentine, D. Thorning, D. Andrews & M. Lilly. Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int. J. Immunopharmacol. 1994, 16, 723-736.
43. Teranishi, M. A. & T. Nakashima: Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs. Int. J. Pediatr. Otorhinolaryngol. 2003, 67, 133-139.
44. Wang, L., W. Ma, R. Markovich, W. L. Lee & P. H. Wang: Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 1998, 139, 1354-1360.
45. Wang, S., E. A. Konorev, S. Kotamraju, J. Joseph, S. Kalivendi & B. Kalyanaraman: Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways. J. Biol. Chem. 2004, 279, 25535-25543.
46. Wang, Y. M., F. F. Madanat, J. C. Kimball, C. A. Gleiser, M. K. Ali, M. W. Kaufman & J. van Eys: Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res. 1980, 40, 1022-1027.
47. Wu, Y., Y. Chen, J. Xu & L. Lu: Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi 2002, 24, 348-352.
48. Yamaoka, M., S. Yamaguchi, T. Suzuki, M. Okuyama, J. Nitobe, N. Nakamura, Y. Mitsui & H. Tomoike: Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J. Mol. Cell. Cardiol. 2000, 32, 881-889.